Thousands of patients who could have received personalized medicine for their cancer tumors were instead given chemotherapy drugs with more toxic side effects and less therapeutic benefit.
While most oncologists say genomic sequencing is an important advance, close to two thirds say only a small percentage of their patients might benefit.
High-throughput genomic analyses may improve outcomes in patients with types of metastatic cancer, according to results of a recent trial published in Cancer Discovery.
A RNA-based digital polymerase chain reaction (PCR) method for analyzing circulating tumor cells greatly improves accuracy in diagnosing hepatocellular carcinoma (HCC), according to a report published in PNAS.
A combination of genomic assays could be an effective precision medicine approach for clinical diagnosis, prognosis, and treatment of pediatric brain tumors.
Breast cancer serves as a model for using precision medicine to guide treatment decisions and improve patients’ quality of life, according to a presentation at the 2016 Lynn Sage Breast Cancer Symposium.